191 related articles for article (PubMed ID: 8735624)
1. Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats.
Hiramatsu M; Mori H; Murasawa H; Kameyama T
Br J Pharmacol; 1996 May; 118(2):255-60. PubMed ID: 8735624
[TBL] [Abstract][Full Text] [Related]
2. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist.
Hiramatsu M; Murasawa H; Mori H; Kameyama T
Br J Pharmacol; 1998 Mar; 123(5):920-6. PubMed ID: 9535021
[TBL] [Abstract][Full Text] [Related]
3. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
4. Dynorphin A (2-13) improves mecamylamine-induced learning impairment accompanied by reversal of reductions in acetylcholine release in rats.
Hiramatsu M; Watanabe E
Neuropeptides; 2006 Feb; 40(1):47-56. PubMed ID: 16313958
[TBL] [Abstract][Full Text] [Related]
5. Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat.
Ogren SO; Kehr J; Schött PA
Neuroscience; 1996 Dec; 75(4):1127-40. PubMed ID: 8938746
[TBL] [Abstract][Full Text] [Related]
6. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.
Hiramatsu M; Kameyama T
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):595-9. PubMed ID: 9819804
[TBL] [Abstract][Full Text] [Related]
7. Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice.
Kameyama T; Ukai M; Miura M
Neuropharmacology; 1994 Oct; 33(10):1167-9. PubMed ID: 7532287
[TBL] [Abstract][Full Text] [Related]
8. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
Ukai M; Itoh J; Kobayashi T; Shinkai N; Kameyama T
Behav Brain Res; 1997 Feb; 83(1-2):169-72. PubMed ID: 9062678
[TBL] [Abstract][Full Text] [Related]
9. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task.
Hiramatsu M; Sasaki M; Kameyama T
Eur J Pharmacol; 1995 Aug; 282(1-3):185-91. PubMed ID: 7498274
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of the neuropeptide galanin on striatal acetylcholine release in anaesthetized and awake rats.
Antoniou K; Kehr J; Snitt K; Ogren SO
Br J Pharmacol; 1997 Jul; 121(6):1180-6. PubMed ID: 9249255
[TBL] [Abstract][Full Text] [Related]
11. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
12. Medial septal galanin and acetylcholine: influence on hippocampal acetylcholine and spatial learning.
Elvander E; Ogren SO
Neuropeptides; 2005 Jun; 39(3):245-8. PubMed ID: 15944017
[TBL] [Abstract][Full Text] [Related]
13. Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition.
Elvander E; Schött PA; Sandin J; Bjelke B; Kehr J; Yoshitake T; Ogren SO
Neuroscience; 2004; 126(3):541-57. PubMed ID: 15183504
[TBL] [Abstract][Full Text] [Related]
14. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
Itoh J; Ukai M; Kameyama T
J Pharmacol Exp Ther; 1994 Apr; 269(1):15-21. PubMed ID: 7909556
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin/orphanin FQ reverses mecamylamine-induced learning and memory impairment as well as decrease in hippocampal acetylcholine release in the rat.
Hiramatsu M; Miwa M; Hashimoto K; Kawai S; Nomura N
Brain Res; 2008 Feb; 1195():96-103. PubMed ID: 18191820
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release.
Ogren SO; Pramanik A; Land T; Langel U
Eur J Pharmacol; 1993 Sep; 242(1):59-64. PubMed ID: 7693496
[TBL] [Abstract][Full Text] [Related]
17. Des-tyrosine(1) dynorphin A-(2-13) improves carbon monoxide-induced impairment of learning and memory in mice.
Hiramatsu M; Inoue K
Brain Res; 2000 Mar; 859(2):303-10. PubMed ID: 10719078
[TBL] [Abstract][Full Text] [Related]
18. Galanin and learning.
Ogren SO; Schött PA; Kehr J; Misane I; Razani H
Brain Res; 1999 Nov; 848(1-2):174-82. PubMed ID: 10612709
[TBL] [Abstract][Full Text] [Related]
19. Galanin differentially regulates acetylcholine release in ventral and dorsal hippocampus: a microdialysis study in awake rat.
Yoshitake T; Yoshitake S; Savage S; Elvander-Tottie E; Ogren SO; Kehr J
Neuroscience; 2011 Dec; 197():172-80. PubMed ID: 21958860
[TBL] [Abstract][Full Text] [Related]
20. Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in mice.
Ukai M; Kobayashi T; Shinkai N; Shan-Wu X; Kameyama T
Eur J Pharmacol; 1995 Feb; 274(1-3):89-93. PubMed ID: 7768285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
